Target type: biologicalprocess
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways involving lipoproteins, any conjugated, water-soluble protein in which the nonprotein group consists of a lipid or lipids. [GOC:ai]
The regulation of lipoprotein metabolic process is a complex and tightly controlled process that involves the coordinated action of multiple genes, enzymes, and proteins. Lipoproteins are complex particles that transport lipids, including cholesterol and triglycerides, through the bloodstream. The regulation of lipoprotein metabolism is crucial for maintaining lipid homeostasis and preventing the development of cardiovascular disease.
**Lipoprotein Metabolism:**
- **Synthesis and Assembly:** Lipoproteins are synthesized in the liver and small intestine. The process begins with the synthesis of apolipoproteins, which are proteins that bind to lipids. Apolipoproteins serve as ligands for lipoprotein receptors and play a role in lipoprotein metabolism.
- **Transport and Delivery:** Lipoproteins transport lipids to different tissues in the body. The different classes of lipoproteins include chylomicrons, very-low-density lipoproteins (VLDL), low-density lipoproteins (LDL), and high-density lipoproteins (HDL).
- **Catabolism and Removal:** Lipoproteins are catabolized by enzymes, such as lipoprotein lipase (LPL) and hepatic lipase (HL). The breakdown products of lipoproteins are then taken up by cells for energy production or re-esterification.
**Regulation of Lipoprotein Metabolism:**
- **Genetic Factors:** Genetic variations in genes involved in lipoprotein metabolism can influence lipoprotein levels. For example, mutations in the LDL receptor gene can lead to familial hypercholesterolemia, a condition characterized by high LDL cholesterol levels.
- **Dietary Factors:** Dietary fat intake plays a significant role in lipoprotein metabolism. A diet high in saturated and trans fats can increase LDL cholesterol levels, while a diet rich in monounsaturated and polyunsaturated fats can increase HDL cholesterol levels.
- **Hormonal Factors:** Hormones such as insulin, glucagon, thyroid hormone, and sex hormones can influence lipoprotein metabolism. For example, insulin promotes the uptake of LDL cholesterol by cells, while glucagon stimulates the synthesis of VLDL.
- **Drug Therapy:** Statins are a class of drugs that inhibit the synthesis of cholesterol by the liver. Other medications, such as bile acid sequestrants and niacin, can also lower LDL cholesterol levels.
**Key Regulators of Lipoprotein Metabolism:**
- **Apolipoproteins:** Apolipoproteins play a crucial role in lipoprotein metabolism. They serve as ligands for lipoprotein receptors, mediate the interaction between lipoproteins and enzymes, and influence the catabolism of lipoproteins.
- **Lipoprotein Lipase (LPL):** LPL is an enzyme that hydrolyzes triglycerides in chylomicrons and VLDL. It is mainly expressed in adipose tissue, muscle, and heart.
- **Hepatic Lipase (HL):** HL is another enzyme that hydrolyzes triglycerides and phospholipids in VLDL and HDL. It is primarily expressed in the liver.
- **LDL Receptor:** The LDL receptor is a protein that binds to LDL and mediates its uptake by cells. It plays a key role in maintaining cholesterol homeostasis.
**Dysregulation of Lipoprotein Metabolism:**
- **Hyperlipidemia:** Hyperlipidemia refers to abnormally high levels of lipids in the blood. It is a major risk factor for cardiovascular disease.
- **Atherosclerosis:** Atherosclerosis is a condition characterized by the buildup of plaque in the arteries. High LDL cholesterol levels contribute to atherosclerosis.
- **Cardiovascular Disease:** Cardiovascular disease, including heart attack and stroke, is a leading cause of death worldwide. Dysregulation of lipoprotein metabolism is a major contributor to cardiovascular disease.'
"
Protein | Definition | Taxonomy |
---|---|---|
Endothelial lipase | An endothelial lipase that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9Y5X9] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
nutlin 3 | stilbenoid | ||
orlistat | orlistat : A carboxylic ester resulting from the formal condensation of the carboxy group of N-formyl-L-leucine with the hydroxy group of (3S,4S)-3-hexyl-4-[(2S)-2-hydroxytridecyl]oxetan-2-one. A pancreatic lipase inhibitor, it is used as an anti-obesity drug. Orlistat: A lactone derivative of LEUCINE that acts as a pancreatic lipase inhibitor to limit the absorption of dietary fat; it is used in the management of obesity. | beta-lactone; carboxylic ester; formamides; L-leucine derivative | anti-obesity agent; bacterial metabolite; EC 2.3.1.85 (fatty acid synthase) inhibitor; EC 3.1.1.3 (triacylglycerol lipase) inhibitor |
xen445 |